Birin, Missal B.
HRN: 07-07-34 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/23/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
01/23/2023
01/30/2023
IV
2.2g
Q6hrs
Dm Foot
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: No Wrong Dose Wrong Dose
Overall appropriateness: No Wrong Dose